Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project (APOF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02032472
Recruitment Status : Completed
First Posted : January 10, 2014
Last Update Posted : January 10, 2014
Sponsor:
Collaborator:
Institut Catala de Salut
Information provided by (Responsible Party):
Jordi Gol i Gurina Foundation

Brief Summary:

Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care.

Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring


Condition or disease Intervention/treatment Phase
Hypertension Other: Measurement of Arterial Pressure Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 677 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project
Study Start Date : January 2010
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2012

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Health Center (usual practice)
Controlling arterial pressure in the health center (a common practice is carried out)
Experimental: Collaboration of pharmacies
Pharmacies cooperate in Measurement of Arterial Pressure of patients
Other: Measurement of Arterial Pressure
Pharmacies cooperate in measuring blood pressure of patients




Primary Outcome Measures :
  1. Percentage of hypertensive patients with criteria for good control of their arterial pressure along one year follow up [ Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010) ]
    We considered as a for good control criterion , obtaining values of systolic arterial pressure to below 140 mm Hg and diastolic blood pressure below 90 mm Hg dea, held along the entire the year follow-up of patients


Secondary Outcome Measures :
  1. reduction in the number of visits to the health center to measure blood pressure [ Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010) ]
    The number of visits to the health center where blood pressure is measured. We hope that the number of visits to the health center where blood pressure is measured is lower in the intervention group (the patients have the option to go to the pharmacy to carrying out checks blood pressure)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age not less than 18 years
  • HTA controlled over 2 years of evolution
  • Subjects with a history open to participating health centers or stable residence in the geographic area
  • Subjects who agree to participate

Exclusion Criteria:

  • Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure
  • Patients with temporary residence in the geographic area of study
  • Subjects of hypertension controlled by outside professionals to our primary care teams.
  • Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period.
  • Subjects with severe diseases of poor prognosis, hopefully less than one year of life.
  • Subjects who do not have telephones.
  • Subjects with communication problems (cognitive impairment, sensory, language barrier)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02032472


Locations
Layout table for location information
Spain
Institut Català de la Salut (ICS)
Cerdanyola del Valllés, Barcelona, Spain, 08290
Sponsors and Collaborators
Jordi Gol i Gurina Foundation
Institut Catala de Salut
Investigators
Layout table for investigator information
Principal Investigator: Oscar Solans, G Physician Institut Català de la Salut (Spain)

Layout table for additonal information
Responsible Party: Jordi Gol i Gurina Foundation
ClinicalTrials.gov Identifier: NCT02032472     History of Changes
Other Study ID Numbers: APOF_IDIAP
First Posted: January 10, 2014    Key Record Dates
Last Update Posted: January 10, 2014
Last Verified: January 2014
Keywords provided by Jordi Gol i Gurina Foundation:
Blood Pressure Monitoring, Ambulatory
Arterial Pressure
Hypertension Controlled
Pharmacies
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases